5Reitam S,Wollenberg A,Schopf E,et al. Safety and efficaey of I year of taerolimus ointment monotherapy in adul|s with atopic dermatitis[J]. Arch Dennato| ,2004,136:999-1006.
6Kang KI, Meng X, Devin-lecerc J, et al. The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorti-costeroid-dependent promoter [J]. Proc Nat Acad Sci USA, 1999,96(4) : 1439-1444.
7Qian X,Zhu Y,Xu W, et al . Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics[J]. Chin Med J (Engl), 2001,114(14) : 1051-1054.
8Hanifin JM. Ling MR, Langley R , et al . Tacrdimus oimtment for the treatment of atopie dermatitis in adult patients : part Ⅰ,efficaey[J]. J Am Acad Dematol , 2001,44(1 suppl) : S28- S38.
9Soter NA , Fleischer AB Jr, Webster GF , et al . Taerolimus ointment for the treatment of atopic dermatitis in adult patients : part Ⅱ, safety[J] . J Am Acad Dermatol, 2001,44 (1 Suppl) : S39-S46.
10Olhnberg A, Sharma S, von Bubnoff D, et al. Topical tacrolimas(FK505) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis [J]. AUergy Clin Immunol, 2001,107 (3) : 519-529.
